The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
Recent news out of Texas gave updates on the cases against three men who were part of a major counterfeit pill ring busted in San Antonio in 2017. The ringleader entered a guilty plea and faces up to 30 years in prison, a supplier received a 21-year sentence, and a distributor waits to see what his future holds…
In June, the New Jersey Assembly passed A-5037, a bill that increases penalties for those who create, distribute or administer counterfeit, adulterated or misbranded medical drugs and devices. The legislation, which has been sent to the New Jersey Senate’s Budget and Appropriations Committee, would make the sale of more than 100 units of fake medicine punishable by a sentence of five to ten years, a fine of up to $150,000, or both.
This editorial by Adam Fein and Dirk Rodgers was published in Stat News on July 11, 2019. In it, Fein and Rodgers warn that plans by states to create drug importation programs will open new pathways for counterfeit drugs to enter the U.S. drug supply chain…
A series of eight different busts in Arizona this month has yielded approximately 132,000 counterfeit pills made with fentanyl, with seizures happening all across the Grand Canyon state.
This editorial by Kentucky State Representative Sal Santoro was published in Kentucky Today on June 27, 2019. In it, Santoro highlights the dangers of fentanyl to law enforcement officers as well as the fact that counterfeit pills made with the dangerous synthetic opioid are killing Americans across the country…
This editorial by retired DEA agent Douglas Hebert was published in The Arizona Capital Times ,on June 27, 2019. In it, Hebert explains how drug importation programs will help organized crime expand their $200 billion-a-year counterfeit pharmaceutical industry into the U.S., at the expense of Americans.
On June 24, 2019, the National Alliance of State Pharmacy Associations (NASPA), along with the American Pharmacists Association (APhA), and the National Association of Chain Drug Stores (NACDS) wrote a joint letter to U.S. Health and Human Services (HSS) Secretary Alex Azar questioning the wisdom of poorly thought-out importation proposals.
In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”
On June 4, 2019, Laval police conducted a series of raids to bring down the ring that was making the counterfeit pills. 235 police officers searched 13 locations in Laval, Montreal and the communities that ring the north shore of Laval and Montreal islands. The raids have resulted in the arrest of eleven people.
On June 7, 2019, a federal jury found Dion Gregory Fisher, 33, of Seminole, FL, guilty of conspiring to manufacture and distribute fentanyl and fentanyl analogue, guilty of five counts of fentanyl distribution and manufacturing and eight counts of committing money laundering transactions involving more than $10,000 of narcotics proceeds.